nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—lung cancer	0.381	0.81	CbGaD
Indacaterol—ABCB1—lung cancer	0.0891	0.19	CbGaD
Indacaterol—UGT1A1—Erlotinib—lung cancer	0.0563	0.146	CbGbCtD
Indacaterol—UGT1A1—Irinotecan—lung cancer	0.0509	0.131	CbGbCtD
Indacaterol—UGT1A1—Etoposide—lung cancer	0.0407	0.105	CbGbCtD
Indacaterol—ABCB1—Topotecan—lung cancer	0.0207	0.0534	CbGbCtD
Indacaterol—ABCB1—Gefitinib—lung cancer	0.0189	0.0488	CbGbCtD
Indacaterol—ABCB1—Vinorelbine—lung cancer	0.0146	0.0376	CbGbCtD
Indacaterol—CYP3A4—Topotecan—lung cancer	0.0124	0.032	CbGbCtD
Indacaterol—ABCB1—Crizotinib—lung cancer	0.0116	0.0299	CbGbCtD
Indacaterol—CYP3A4—Gefitinib—lung cancer	0.0113	0.0292	CbGbCtD
Indacaterol—ABCB1—Gemcitabine—lung cancer	0.0113	0.0292	CbGbCtD
Indacaterol—ABCB1—Erlotinib—lung cancer	0.0112	0.0289	CbGbCtD
Indacaterol—CYP3A4—Teniposide—lung cancer	0.011	0.0284	CbGbCtD
Indacaterol—ABCB1—Paclitaxel—lung cancer	0.0102	0.0264	CbGbCtD
Indacaterol—ABCB1—Irinotecan—lung cancer	0.0101	0.0261	CbGbCtD
Indacaterol—ABCB1—Vinblastine—lung cancer	0.00897	0.0232	CbGbCtD
Indacaterol—CYP3A4—Vinorelbine—lung cancer	0.00872	0.0225	CbGbCtD
Indacaterol—ABCB1—Cisplatin—lung cancer	0.00822	0.0212	CbGbCtD
Indacaterol—ABCB1—Etoposide—lung cancer	0.00808	0.0209	CbGbCtD
Indacaterol—ABCB1—Docetaxel—lung cancer	0.00739	0.0191	CbGbCtD
Indacaterol—CYP3A4—Crizotinib—lung cancer	0.00694	0.0179	CbGbCtD
Indacaterol—CYP3A4—Erlotinib—lung cancer	0.00669	0.0173	CbGbCtD
Indacaterol—CYP3A4—Paclitaxel—lung cancer	0.00613	0.0158	CbGbCtD
Indacaterol—CYP3A4—Irinotecan—lung cancer	0.00604	0.0156	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—lung cancer	0.00551	0.0142	CbGbCtD
Indacaterol—CYP3A4—Vinblastine—lung cancer	0.00537	0.0139	CbGbCtD
Indacaterol—ABCB1—Methotrexate—lung cancer	0.00534	0.0138	CbGbCtD
Indacaterol—CYP3A4—Etoposide—lung cancer	0.00484	0.0125	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—lung cancer	0.00443	0.0114	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—lung cancer	0.0033	0.00853	CbGbCtD
Indacaterol—Gastrointestinal disorder—Topotecan—lung cancer	0.000208	0.00215	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Erlotinib—lung cancer	0.000206	0.00213	CcSEcCtD
Indacaterol—Rash—Teniposide—lung cancer	0.000205	0.00212	CcSEcCtD
Indacaterol—Dermatitis—Teniposide—lung cancer	0.000205	0.00212	CcSEcCtD
Indacaterol—Infection—Vinorelbine—lung cancer	0.000205	0.00212	CcSEcCtD
Indacaterol—Sinusitis—Paclitaxel—lung cancer	0.000204	0.00211	CcSEcCtD
Indacaterol—Headache—Teniposide—lung cancer	0.000204	0.00211	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—lung cancer	0.000203	0.0021	CcSEcCtD
Indacaterol—Nervous system disorder—Vinorelbine—lung cancer	0.000202	0.00209	CcSEcCtD
Indacaterol—Cardiac disorder—Cisplatin—lung cancer	0.000202	0.00209	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—lung cancer	0.000201	0.00208	CcSEcCtD
Indacaterol—Tachycardia—Vinorelbine—lung cancer	0.000201	0.00208	CcSEcCtD
Indacaterol—Muscle spasms—Irinotecan—lung cancer	0.0002	0.00207	CcSEcCtD
Indacaterol—Skin disorder—Vinorelbine—lung cancer	0.0002	0.00207	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—lung cancer	0.000198	0.00205	CcSEcCtD
Indacaterol—Immune system disorder—Cisplatin—lung cancer	0.000196	0.00203	CcSEcCtD
Indacaterol—Mediastinal disorder—Cisplatin—lung cancer	0.000196	0.00203	CcSEcCtD
Indacaterol—Nausea—Teniposide—lung cancer	0.000193	0.002	CcSEcCtD
Indacaterol—Anaemia—Irinotecan—lung cancer	0.000193	0.00199	CcSEcCtD
Indacaterol—Oedema peripheral—Paclitaxel—lung cancer	0.000192	0.00199	CcSEcCtD
Indacaterol—Connective tissue disorder—Paclitaxel—lung cancer	0.000192	0.00198	CcSEcCtD
Indacaterol—Malnutrition—Cisplatin—lung cancer	0.000189	0.00196	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000188	0.00194	CcSEcCtD
Indacaterol—Anaemia—Gemcitabine—lung cancer	0.000188	0.00194	CcSEcCtD
Indacaterol—Vertigo—Irinotecan—lung cancer	0.000187	0.00194	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—lung cancer	0.000185	0.00192	CcSEcCtD
Indacaterol—Paraesthesia—Vinorelbine—lung cancer	0.000185	0.00192	CcSEcCtD
Indacaterol—Cardiac disorder—Etoposide—lung cancer	0.000185	0.00191	CcSEcCtD
Indacaterol—Infestation—Docetaxel—lung cancer	0.000184	0.00191	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—lung cancer	0.000184	0.00191	CcSEcCtD
Indacaterol—Dyspnoea—Vinorelbine—lung cancer	0.000184	0.0019	CcSEcCtD
Indacaterol—Hypersensitivity—Vinblastine—lung cancer	0.000183	0.00189	CcSEcCtD
Indacaterol—Muscle spasms—Cisplatin—lung cancer	0.000182	0.00188	CcSEcCtD
Indacaterol—Cough—Irinotecan—lung cancer	0.000182	0.00188	CcSEcCtD
Indacaterol—Cardiac disorder—Paclitaxel—lung cancer	0.000181	0.00187	CcSEcCtD
Indacaterol—Immune system disorder—Etoposide—lung cancer	0.00018	0.00186	CcSEcCtD
Indacaterol—Mediastinal disorder—Etoposide—lung cancer	0.000179	0.00186	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000178	0.00184	CcSEcCtD
Indacaterol—Hypersensitivity—Topotecan—lung cancer	0.000178	0.00184	CcSEcCtD
Indacaterol—Tremor—Cisplatin—lung cancer	0.000177	0.00183	CcSEcCtD
Indacaterol—Cough—Gemcitabine—lung cancer	0.000177	0.00183	CcSEcCtD
Indacaterol—Immune system disorder—Paclitaxel—lung cancer	0.000176	0.00182	CcSEcCtD
Indacaterol—Mediastinal disorder—Paclitaxel—lung cancer	0.000176	0.00182	CcSEcCtD
Indacaterol—Anaemia—Cisplatin—lung cancer	0.000175	0.00181	CcSEcCtD
Indacaterol—Myalgia—Gemcitabine—lung cancer	0.000173	0.00179	CcSEcCtD
Indacaterol—Chest pain—Gemcitabine—lung cancer	0.000173	0.00179	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—lung cancer	0.000172	0.00178	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000172	0.00178	CcSEcCtD
Indacaterol—Pruritus—Topotecan—lung cancer	0.000171	0.00176	CcSEcCtD
Indacaterol—Malnutrition—Paclitaxel—lung cancer	0.00017	0.00176	CcSEcCtD
Indacaterol—Infection—Irinotecan—lung cancer	0.000169	0.00175	CcSEcCtD
Indacaterol—Pruritus—Erlotinib—lung cancer	0.000169	0.00175	CcSEcCtD
Indacaterol—Nervous system disorder—Irinotecan—lung cancer	0.000167	0.00173	CcSEcCtD
Indacaterol—Muscle spasms—Etoposide—lung cancer	0.000167	0.00172	CcSEcCtD
Indacaterol—Infection—Gemcitabine—lung cancer	0.000165	0.0017	CcSEcCtD
Indacaterol—Dizziness—Vinblastine—lung cancer	0.000164	0.0017	CcSEcCtD
Indacaterol—Muscle spasms—Paclitaxel—lung cancer	0.000163	0.00169	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—lung cancer	0.000163	0.00169	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—lung cancer	0.000163	0.00168	CcSEcCtD
Indacaterol—Nervous system disorder—Gemcitabine—lung cancer	0.000162	0.00168	CcSEcCtD
Indacaterol—Myalgia—Cisplatin—lung cancer	0.000161	0.00167	CcSEcCtD
Indacaterol—Skin disorder—Gemcitabine—lung cancer	0.000161	0.00166	CcSEcCtD
Indacaterol—Anaemia—Etoposide—lung cancer	0.00016	0.00166	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00016	0.00165	CcSEcCtD
Indacaterol—Dizziness—Topotecan—lung cancer	0.000159	0.00165	CcSEcCtD
Indacaterol—Tremor—Paclitaxel—lung cancer	0.000159	0.00165	CcSEcCtD
Indacaterol—Dizziness—Erlotinib—lung cancer	0.000158	0.00163	CcSEcCtD
Indacaterol—Anaemia—Paclitaxel—lung cancer	0.000157	0.00162	CcSEcCtD
Indacaterol—Vertigo—Etoposide—lung cancer	0.000156	0.00161	CcSEcCtD
Indacaterol—Headache—Vinblastine—lung cancer	0.000155	0.00161	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—lung cancer	0.000154	0.00159	CcSEcCtD
Indacaterol—Infection—Cisplatin—lung cancer	0.000153	0.00159	CcSEcCtD
Indacaterol—Paraesthesia—Irinotecan—lung cancer	0.000153	0.00158	CcSEcCtD
Indacaterol—Vertigo—Paclitaxel—lung cancer	0.000153	0.00158	CcSEcCtD
Indacaterol—Rash—Topotecan—lung cancer	0.000152	0.00157	CcSEcCtD
Indacaterol—Hypersensitivity—Vinorelbine—lung cancer	0.000152	0.00157	CcSEcCtD
Indacaterol—Dermatitis—Topotecan—lung cancer	0.000152	0.00157	CcSEcCtD
Indacaterol—Dyspnoea—Irinotecan—lung cancer	0.000152	0.00157	CcSEcCtD
Indacaterol—Nervous system disorder—Cisplatin—lung cancer	0.000151	0.00157	CcSEcCtD
Indacaterol—Cough—Etoposide—lung cancer	0.000151	0.00156	CcSEcCtD
Indacaterol—Headache—Topotecan—lung cancer	0.000151	0.00156	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000151	0.00156	CcSEcCtD
Indacaterol—Tachycardia—Cisplatin—lung cancer	0.000151	0.00156	CcSEcCtD
Indacaterol—Rash—Erlotinib—lung cancer	0.00015	0.00156	CcSEcCtD
Indacaterol—Dermatitis—Erlotinib—lung cancer	0.00015	0.00155	CcSEcCtD
Indacaterol—Palpitations—Paclitaxel—lung cancer	0.00015	0.00155	CcSEcCtD
Indacaterol—Skin disorder—Cisplatin—lung cancer	0.00015	0.00155	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—lung cancer	0.000149	0.00155	CcSEcCtD
Indacaterol—Headache—Erlotinib—lung cancer	0.000149	0.00155	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—lung cancer	0.000149	0.00154	CcSEcCtD
Indacaterol—Asthma—Methotrexate—lung cancer	0.000149	0.00154	CcSEcCtD
Indacaterol—Paraesthesia—Gemcitabine—lung cancer	0.000149	0.00154	CcSEcCtD
Indacaterol—Cough—Paclitaxel—lung cancer	0.000148	0.00153	CcSEcCtD
Indacaterol—Dyspnoea—Gemcitabine—lung cancer	0.000148	0.00153	CcSEcCtD
Indacaterol—Chest pain—Etoposide—lung cancer	0.000148	0.00153	CcSEcCtD
Indacaterol—Nausea—Vinblastine—lung cancer	0.000147	0.00152	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Irinotecan—lung cancer	0.000147	0.00152	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000147	0.00152	CcSEcCtD
Indacaterol—Pruritus—Vinorelbine—lung cancer	0.000146	0.00151	CcSEcCtD
Indacaterol—Myalgia—Paclitaxel—lung cancer	0.000145	0.0015	CcSEcCtD
Indacaterol—Chest pain—Paclitaxel—lung cancer	0.000145	0.0015	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—lung cancer	0.000144	0.00149	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000144	0.00149	CcSEcCtD
Indacaterol—Nausea—Topotecan—lung cancer	0.000143	0.00148	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000143	0.00148	CcSEcCtD
Indacaterol—Nausea—Erlotinib—lung cancer	0.000142	0.00147	CcSEcCtD
Indacaterol—Dry mouth—Paclitaxel—lung cancer	0.000142	0.00146	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000141	0.00146	CcSEcCtD
Indacaterol—Infection—Etoposide—lung cancer	0.000141	0.00145	CcSEcCtD
Indacaterol—Paraesthesia—Cisplatin—lung cancer	0.000139	0.00143	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—lung cancer	0.000139	0.00143	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—lung cancer	0.000139	0.00143	CcSEcCtD
Indacaterol—Tachycardia—Etoposide—lung cancer	0.000138	0.00143	CcSEcCtD
Indacaterol—Infection—Paclitaxel—lung cancer	0.000138	0.00143	CcSEcCtD
Indacaterol—Dyspnoea—Cisplatin—lung cancer	0.000138	0.00142	CcSEcCtD
Indacaterol—Skin disorder—Etoposide—lung cancer	0.000137	0.00142	CcSEcCtD
Indacaterol—Dizziness—Vinorelbine—lung cancer	0.000136	0.00141	CcSEcCtD
Indacaterol—Nervous system disorder—Paclitaxel—lung cancer	0.000136	0.00141	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—lung cancer	0.000136	0.00141	CcSEcCtD
Indacaterol—Tachycardia—Paclitaxel—lung cancer	0.000135	0.0014	CcSEcCtD
Indacaterol—Skin disorder—Paclitaxel—lung cancer	0.000135	0.00139	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—lung cancer	0.000134	0.00138	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—lung cancer	0.000134	0.00138	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cisplatin—lung cancer	0.000133	0.00138	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—lung cancer	0.000133	0.00138	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—lung cancer	0.000133	0.00137	CcSEcCtD
Indacaterol—Infestation—Methotrexate—lung cancer	0.000133	0.00137	CcSEcCtD
Indacaterol—Rash—Vinorelbine—lung cancer	0.00013	0.00134	CcSEcCtD
Indacaterol—Dermatitis—Vinorelbine—lung cancer	0.00013	0.00134	CcSEcCtD
Indacaterol—Headache—Vinorelbine—lung cancer	0.000129	0.00134	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—lung cancer	0.000129	0.00133	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—lung cancer	0.000127	0.00132	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—lung cancer	0.000127	0.00131	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000126	0.00131	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—lung cancer	0.000126	0.0013	CcSEcCtD
Indacaterol—Cough—Docetaxel—lung cancer	0.000126	0.0013	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—lung cancer	0.000126	0.0013	CcSEcCtD
Indacaterol—Hypersensitivity—Irinotecan—lung cancer	0.000125	0.0013	CcSEcCtD
Indacaterol—Paraesthesia—Paclitaxel—lung cancer	0.000125	0.00129	CcSEcCtD
Indacaterol—Dyspnoea—Paclitaxel—lung cancer	0.000124	0.00128	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—lung cancer	0.000123	0.00127	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—lung cancer	0.000123	0.00127	CcSEcCtD
Indacaterol—Nausea—Vinorelbine—lung cancer	0.000123	0.00127	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—lung cancer	0.000122	0.00126	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000122	0.00126	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—lung cancer	0.00012	0.00124	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—lung cancer	0.00012	0.00124	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00012	0.00124	CcSEcCtD
Indacaterol—Pruritus—Gemcitabine—lung cancer	0.000117	0.00121	CcSEcCtD
Indacaterol—Infection—Docetaxel—lung cancer	0.000117	0.00121	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—lung cancer	0.000116	0.0012	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—lung cancer	0.000116	0.0012	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—lung cancer	0.000115	0.00119	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—lung cancer	0.000115	0.00119	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—lung cancer	0.000115	0.00119	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—lung cancer	0.000115	0.00119	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—lung cancer	0.000114	0.00118	CcSEcCtD
Indacaterol—Hypersensitivity—Cisplatin—lung cancer	0.000114	0.00118	CcSEcCtD
Indacaterol—Dizziness—Irinotecan—lung cancer	0.000112	0.00116	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—lung cancer	0.000111	0.00114	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—lung cancer	0.000108	0.00112	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—lung cancer	0.000108	0.00111	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—lung cancer	0.000108	0.00111	CcSEcCtD
Indacaterol—Rash—Irinotecan—lung cancer	0.000107	0.00111	CcSEcCtD
Indacaterol—Dermatitis—Irinotecan—lung cancer	0.000107	0.00111	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000107	0.00111	CcSEcCtD
Indacaterol—Headache—Irinotecan—lung cancer	0.000107	0.0011	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—lung cancer	0.000106	0.00109	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—lung cancer	0.000105	0.00108	CcSEcCtD
Indacaterol—Rash—Gemcitabine—lung cancer	0.000104	0.00108	CcSEcCtD
Indacaterol—Dermatitis—Gemcitabine—lung cancer	0.000104	0.00108	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—lung cancer	0.000104	0.00108	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—lung cancer	0.000104	0.00107	CcSEcCtD
Indacaterol—Headache—Gemcitabine—lung cancer	0.000104	0.00107	CcSEcCtD
Indacaterol—Hypersensitivity—Paclitaxel—lung cancer	0.000102	0.00106	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—lung cancer	0.000102	0.00105	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—lung cancer	0.000102	0.00105	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—lung cancer	0.000101	0.00105	CcSEcCtD
Indacaterol—Nausea—Irinotecan—lung cancer	0.000101	0.00104	CcSEcCtD
Indacaterol—Pruritus—Etoposide—lung cancer	0.0001	0.00104	CcSEcCtD
Indacaterol—Nausea—Gemcitabine—lung cancer	9.84e-05	0.00102	CcSEcCtD
Indacaterol—Pruritus—Paclitaxel—lung cancer	9.81e-05	0.00101	CcSEcCtD
Indacaterol—Rash—Cisplatin—lung cancer	9.74e-05	0.00101	CcSEcCtD
Indacaterol—Dermatitis—Cisplatin—lung cancer	9.73e-05	0.00101	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—lung cancer	9.6e-05	0.000993	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—lung cancer	9.59e-05	0.000991	CcSEcCtD
Indacaterol—Dizziness—Etoposide—lung cancer	9.36e-05	0.000968	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—lung cancer	9.33e-05	0.000965	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—lung cancer	9.33e-05	0.000965	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—lung cancer	9.31e-05	0.000963	CcSEcCtD
Indacaterol—Dizziness—Paclitaxel—lung cancer	9.17e-05	0.000949	CcSEcCtD
Indacaterol—Nausea—Cisplatin—lung cancer	9.17e-05	0.000949	CcSEcCtD
Indacaterol—Cough—Methotrexate—lung cancer	9.06e-05	0.000937	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—lung cancer	8.99e-05	0.00093	CcSEcCtD
Indacaterol—Rash—Etoposide—lung cancer	8.92e-05	0.000923	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—lung cancer	8.91e-05	0.000922	CcSEcCtD
Indacaterol—Headache—Etoposide—lung cancer	8.86e-05	0.000917	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—lung cancer	8.84e-05	0.000914	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—lung cancer	8.84e-05	0.000914	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.78e-05	0.000908	CcSEcCtD
Indacaterol—Rash—Paclitaxel—lung cancer	8.75e-05	0.000905	CcSEcCtD
Indacaterol—Dermatitis—Paclitaxel—lung cancer	8.74e-05	0.000904	CcSEcCtD
Indacaterol—Headache—Paclitaxel—lung cancer	8.69e-05	0.000899	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—lung cancer	8.66e-05	0.000896	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—lung cancer	8.64e-05	0.000894	CcSEcCtD
Indacaterol—Infection—Methotrexate—lung cancer	8.42e-05	0.000871	CcSEcCtD
Indacaterol—Nausea—Etoposide—lung cancer	8.4e-05	0.000869	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—lung cancer	8.32e-05	0.00086	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—lung cancer	8.31e-05	0.000859	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—lung cancer	8.31e-05	0.000859	CcSEcCtD
Indacaterol—Nausea—Paclitaxel—lung cancer	8.24e-05	0.000852	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—lung cancer	8.23e-05	0.000851	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—lung cancer	8.08e-05	0.000835	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—lung cancer	7.95e-05	0.000822	CcSEcCtD
Indacaterol—Cough—Doxorubicin—lung cancer	7.85e-05	0.000811	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—lung cancer	7.78e-05	0.000804	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—lung cancer	7.72e-05	0.000798	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—lung cancer	7.65e-05	0.000792	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—lung cancer	7.65e-05	0.000792	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—lung cancer	7.61e-05	0.000787	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.6e-05	0.000786	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—lung cancer	7.56e-05	0.000781	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—lung cancer	7.49e-05	0.000774	CcSEcCtD
Indacaterol—Rash—Docetaxel—lung cancer	7.41e-05	0.000767	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—lung cancer	7.41e-05	0.000766	CcSEcCtD
Indacaterol—Headache—Docetaxel—lung cancer	7.37e-05	0.000762	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—lung cancer	7.32e-05	0.000757	CcSEcCtD
Indacaterol—Infection—Doxorubicin—lung cancer	7.29e-05	0.000754	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—lung cancer	7.2e-05	0.000744	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—lung cancer	7.16e-05	0.000741	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—lung cancer	7.13e-05	0.000737	CcSEcCtD
Indacaterol—Nausea—Docetaxel—lung cancer	6.98e-05	0.000722	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.69e-05	0.000691	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—lung cancer	6.59e-05	0.000681	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—lung cancer	6.54e-05	0.000677	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—lung cancer	6.34e-05	0.000655	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—lung cancer	6.24e-05	0.000646	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—lung cancer	6e-05	0.00062	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—lung cancer	5.6e-05	0.00058	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—lung cancer	5.41e-05	0.000559	CcSEcCtD
Indacaterol—Rash—Methotrexate—lung cancer	5.34e-05	0.000553	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—lung cancer	5.34e-05	0.000552	CcSEcCtD
Indacaterol—Headache—Methotrexate—lung cancer	5.31e-05	0.000549	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—lung cancer	5.19e-05	0.000537	CcSEcCtD
Indacaterol—Nausea—Methotrexate—lung cancer	5.03e-05	0.000521	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—lung cancer	4.85e-05	0.000502	CcSEcCtD
Indacaterol—Rash—Doxorubicin—lung cancer	4.63e-05	0.000478	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—lung cancer	4.62e-05	0.000478	CcSEcCtD
Indacaterol—Headache—Doxorubicin—lung cancer	4.6e-05	0.000475	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—lung cancer	4.36e-05	0.000451	CcSEcCtD
Indacaterol—ABCB1—Metabolism—GSTA1—lung cancer	1.08e-05	0.000235	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUNB—lung cancer	1.08e-05	0.000234	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.07e-05	0.000233	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ABCC3—lung cancer	1.07e-05	0.000233	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	1.07e-05	0.000232	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	1.05e-05	0.000227	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKR1C1—lung cancer	1.04e-05	0.000225	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	1.03e-05	0.000225	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CKB—lung cancer	1.02e-05	0.000222	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—POMC—lung cancer	1.02e-05	0.000221	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	1.01e-05	0.00022	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—UGT1A1—lung cancer	1.01e-05	0.000219	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STK11—lung cancer	1e-05	0.000217	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—POMC—lung cancer	9.95e-06	0.000216	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6R—lung cancer	9.93e-06	0.000216	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	9.86e-06	0.000214	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STK11—lung cancer	9.78e-06	0.000213	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6R—lung cancer	9.71e-06	0.000211	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GNG11—lung cancer	9.71e-06	0.000211	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FOXO3—lung cancer	9.65e-06	0.00021	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM2—lung cancer	9.62e-06	0.000209	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CNDP2—lung cancer	9.62e-06	0.000209	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.54e-06	0.000207	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	9.46e-06	0.000206	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FOXO3—lung cancer	9.44e-06	0.000205	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	9.4e-06	0.000204	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOA1—lung cancer	9.37e-06	0.000204	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTMR3—lung cancer	9.36e-06	0.000203	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	9.25e-06	0.000201	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDOA—lung cancer	9.24e-06	0.000201	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	9.19e-06	0.0002	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.18e-06	0.0002	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PGAM1—lung cancer	9.12e-06	0.000198	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AVP—lung cancer	9.05e-06	0.000197	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	9.02e-06	0.000196	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NCOA3—lung cancer	8.97e-06	0.000195	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AVP—lung cancer	8.85e-06	0.000192	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	8.82e-06	0.000192	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADCY1—lung cancer	8.73e-06	0.00019	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ABCG2—lung cancer	8.73e-06	0.00019	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1R—lung cancer	8.71e-06	0.000189	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2A7—lung cancer	8.7e-06	0.000189	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	8.67e-06	0.000188	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ENO2—lung cancer	8.56e-06	0.000186	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HPGDS—lung cancer	8.56e-06	0.000186	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CG—lung cancer	8.56e-06	0.000186	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HES1—lung cancer	8.55e-06	0.000186	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1R—lung cancer	8.52e-06	0.000185	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SDC4—lung cancer	8.52e-06	0.000185	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPP2R1B—lung cancer	8.5e-06	0.000185	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	8.48e-06	0.000184	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—RAF1—lung cancer	8.39e-06	0.000182	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HES1—lung cancer	8.37e-06	0.000182	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—lung cancer	8.3e-06	0.00018	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—lung cancer	8.28e-06	0.00018	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—RAF1—lung cancer	8.21e-06	0.000178	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCLC—lung cancer	8.21e-06	0.000178	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2A6—lung cancer	8.21e-06	0.000178	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	8.19e-06	0.000178	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—POMC—lung cancer	8.15e-06	0.000177	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—lung cancer	8.1e-06	0.000176	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.06e-06	0.000175	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	8.01e-06	0.000174	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CREBBP—lung cancer	7.94e-06	0.000172	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	7.87e-06	0.000171	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB3—lung cancer	7.82e-06	0.00017	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ENO1—lung cancer	7.78e-06	0.000169	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	7.77e-06	0.000169	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—RRM1—lung cancer	7.76e-06	0.000169	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTA3—lung cancer	7.76e-06	0.000169	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	7.7e-06	0.000167	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB3—lung cancer	7.65e-06	0.000166	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CD—lung cancer	7.52e-06	0.000164	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—lung cancer	7.52e-06	0.000164	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TERT—lung cancer	7.5e-06	0.000163	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—lung cancer	7.43e-06	0.000161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—lung cancer	7.36e-06	0.00016	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TERT—lung cancer	7.33e-06	0.000159	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—B4GALT5—lung cancer	7.29e-06	0.000159	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGFR1—lung cancer	7.28e-06	0.000158	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.27e-06	0.000158	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—lung cancer	7.17e-06	0.000156	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGFR1—lung cancer	7.12e-06	0.000155	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTA4—lung cancer	7.09e-06	0.000154	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—lung cancer	7.01e-06	0.000152	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2E1—lung cancer	6.98e-06	0.000152	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOA1—lung cancer	6.92e-06	0.00015	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTA2—lung cancer	6.91e-06	0.00015	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NQO1—lung cancer	6.9e-06	0.00015	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—lung cancer	6.86e-06	0.000149	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOA1—lung cancer	6.77e-06	0.000147	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—lung cancer	6.71e-06	0.000146	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTA1—lung cancer	6.67e-06	0.000145	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCC3—lung cancer	6.6e-06	0.000143	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.58e-06	0.000143	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CB—lung cancer	6.56e-06	0.000143	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—lung cancer	6.5e-06	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKR1C1—lung cancer	6.39e-06	0.000139	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APC—lung cancer	6.32e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	6.32e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KIT—lung cancer	6.32e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—NRAS—lung cancer	6.31e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGF—lung cancer	6.24e-06	0.000136	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—STK11—lung cancer	6.22e-06	0.000135	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UGT1A1—lung cancer	6.2e-06	0.000135	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APC—lung cancer	6.18e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KIT—lung cancer	6.18e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	6.18e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—NRAS—lung cancer	6.18e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGF—lung cancer	6.11e-06	0.000133	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	6.05e-06	0.000131	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—POMC—lung cancer	6.01e-06	0.000131	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GNG11—lung cancer	5.98e-06	0.00013	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BRAF—lung cancer	5.94e-06	0.000129	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	5.92e-06	0.000129	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—POMC—lung cancer	5.88e-06	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6R—lung cancer	5.86e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CREBBP—lung cancer	5.86e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BRAF—lung cancer	5.81e-06	0.000126	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—lung cancer	5.75e-06	0.000125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—lung cancer	5.75e-06	0.000125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6R—lung cancer	5.74e-06	0.000125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CREBBP—lung cancer	5.73e-06	0.000124	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDOA—lung cancer	5.69e-06	0.000124	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—lung cancer	5.67e-06	0.000123	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—lung cancer	5.63e-06	0.000122	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAT—lung cancer	5.6e-06	0.000122	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	5.59e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	5.55e-06	0.000121	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOA3—lung cancer	5.53e-06	0.00012	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	5.5e-06	0.00012	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	5.47e-06	0.000119	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—lung cancer	5.44e-06	0.000118	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	5.43e-06	0.000118	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—EP300—lung cancer	5.4e-06	0.000117	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	5.38e-06	0.000117	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADCY1—lung cancer	5.38e-06	0.000117	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCG2—lung cancer	5.38e-06	0.000117	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TYMS—lung cancer	5.35e-06	0.000116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—lung cancer	5.32e-06	0.000116	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—lung cancer	5.29e-06	0.000115	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HPGDS—lung cancer	5.27e-06	0.000115	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENO2—lung cancer	5.27e-06	0.000115	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.24e-06	0.000114	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—lung cancer	5.11e-06	0.000111	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2A6—lung cancer	5.06e-06	0.00011	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCLC—lung cancer	5.06e-06	0.00011	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1A1—lung cancer	5.01e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	4.99e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MDM2—lung cancer	4.97e-06	0.000108	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ERCC2—lung cancer	4.97e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAF1—lung cancer	4.96e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB2—lung cancer	4.9e-06	0.000107	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	4.88e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MDM2—lung cancer	4.87e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAF1—lung cancer	4.85e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MTOR—lung cancer	4.84e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	4.84e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB2—lung cancer	4.8e-06	0.000104	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENO1—lung cancer	4.79e-06	0.000104	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	4.73e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MTOR—lung cancer	4.73e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—lung cancer	4.65e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRAS—lung cancer	4.62e-06	0.0001	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—lung cancer	4.55e-06	9.89e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRAS—lung cancer	4.52e-06	9.82e-05	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	4.49e-06	9.76e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—lung cancer	4.45e-06	9.67e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—lung cancer	4.44e-06	9.66e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—lung cancer	4.42e-06	9.61e-05	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	4.39e-06	9.55e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—lung cancer	4.35e-06	9.46e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—lung cancer	4.35e-06	9.45e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—lung cancer	4.33e-06	9.42e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—lung cancer	4.33e-06	9.4e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUN—lung cancer	4.32e-06	9.4e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOA1—lung cancer	4.3e-06	9.35e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2E1—lung cancer	4.3e-06	9.34e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NQO1—lung cancer	4.25e-06	9.24e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—lung cancer	4.24e-06	9.21e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUN—lung cancer	4.23e-06	9.19e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—lung cancer	4.21e-06	9.14e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	4.19e-06	9.11e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—lung cancer	4.18e-06	9.09e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—lung cancer	4.11e-06	8.94e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	4.1e-06	8.91e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—lung cancer	4.09e-06	8.89e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—lung cancer	4.08e-06	8.87e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—lung cancer	4e-06	8.69e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—lung cancer	3.99e-06	8.67e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EP300—lung cancer	3.99e-06	8.67e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CG—lung cancer	3.93e-06	8.53e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EP300—lung cancer	3.9e-06	8.48e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SRC—lung cancer	3.88e-06	8.43e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—STK11—lung cancer	3.83e-06	8.33e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SRC—lung cancer	3.79e-06	8.24e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—lung cancer	3.78e-06	8.21e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—lung cancer	3.74e-06	8.13e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—POMC—lung cancer	3.74e-06	8.12e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NRAS—lung cancer	3.73e-06	8.11e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—lung cancer	3.69e-06	8.03e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—lung cancer	3.66e-06	7.95e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NRAS—lung cancer	3.65e-06	7.93e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CREBBP—lung cancer	3.64e-06	7.91e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK3—lung cancer	3.57e-06	7.77e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—lung cancer	3.54e-06	7.71e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK3—lung cancer	3.49e-06	7.6e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—lung cancer	3.47e-06	7.55e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CD—lung cancer	3.45e-06	7.5e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAT—lung cancer	3.45e-06	7.5e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—lung cancer	3.41e-06	7.41e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—lung cancer	3.4e-06	7.39e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—lung cancer	3.4e-06	7.39e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCB1—lung cancer	3.36e-06	7.29e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—lung cancer	3.32e-06	7.23e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TYMS—lung cancer	3.3e-06	7.16e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—lung cancer	3.27e-06	7.1e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—lung cancer	3.26e-06	7.08e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—lung cancer	3.21e-06	6.98e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—lung cancer	3.14e-06	6.83e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1A1—lung cancer	3.09e-06	6.71e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ERCC2—lung cancer	3.06e-06	6.66e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CB—lung cancer	3.01e-06	6.54e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—lung cancer	2.98e-06	6.48e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	2.95e-06	6.41e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	2.89e-06	6.27e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—lung cancer	2.85e-06	6.2e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—lung cancer	2.79e-06	6.07e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRAS—lung cancer	2.73e-06	5.93e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRAS—lung cancer	2.67e-06	5.8e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOA1—lung cancer	2.65e-06	5.76e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—lung cancer	2.61e-06	5.68e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—lung cancer	2.6e-06	5.65e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—lung cancer	2.56e-06	5.55e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—EP300—lung cancer	2.48e-06	5.39e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CG—lung cancer	2.42e-06	5.26e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—lung cancer	2.41e-06	5.24e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—lung cancer	2.36e-06	5.12e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—POMC—lung cancer	2.3e-06	5e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CREBBP—lung cancer	2.24e-06	4.87e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CD—lung cancer	2.13e-06	4.62e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—lung cancer	2.1e-06	4.56e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CB—lung cancer	1.85e-06	4.03e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—lung cancer	1.84e-06	3.99e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—lung cancer	1.83e-06	3.99e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—lung cancer	1.6e-06	3.48e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—EP300—lung cancer	1.53e-06	3.32e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—lung cancer	1.5e-06	3.26e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—lung cancer	1.13e-06	2.46e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—lung cancer	9.23e-07	2.01e-05	CbGpPWpGaD
